Clinical Trials Browser

Lung Neoplasms × trifluridine tipiracil drug combination × 90 days × Clear all

NCT04701476 2026-04-16

TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

Phase 2 Recruiting

GastrointestinalThoracic

Lung Neoplasms, Colorectal Neoplasms